- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Dealmaking Sweeps the Biotech Sector
-
Healthcare: Branded Pharma Out, Diagnostics/Generics In
-
Generic Players Continue to Impress in H1
-
Women's Health: After WHI, What's the Potential Market Size?
-
Smaller Pharma Wins the 'Most Valuable' Race
-
Hedge Fund Moore Stakes Out Energy Bets
-
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
-
10 New Stock Indexes for Tracking Healthcare Trends
-
Pfizer: Still Limited Upside
-
51 Option Ideas for Bears
-
Redefining Pharma as Biotech Dominates Industry's Growth
-
Biotech Set to Capture 50% of Top 100 Drugs by 2014
-
Biotech Set to Dominate Drug Industry Growth
-
6 Healthcare Stocks to Watch
-
Six Solid Dividend Payers That Look Attractive
-
Wednesday's Healthcare Market Movers
-
Shumway Beefs Up Teva, Cisco Positions
-
Galleon Bets Heavily on the S&P 500
-
Bio Medical Stock Sector is Where the Action Is
-
Health Care Trends Part 2: M&A, Generic Competition, CROs
-
Lee Ainslie's Maverick Capital Sells CVS Caremark in Favor of Walgreens: 13F Filing Q1 2009
-
Timothy Barakett's Atticus Capital Drastically Scales Back Portfolio: 13F Filing Q1 2009
-
Screening for Yielding, Growing, Rising Stocks
-
Einhorn's Greenlight Capital's Big Bets on Gold: 13F Filing - Q1
-
Hedge Fund Eton Park Saw Golden Opportunities in Q109
-
Schering Plough's Mysterious Suitor Before Merck
-
What's John Paulson Buying Now? Hint... Think Gold
-
Latest Trend Leaders
-
FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX
-
An Alzheimer's Expert Discusses the Next Generation of Drugs
-
Wall Street Breakfast: Must-Know News
-
Preview from Europe: Swine Flu, Stress Tests and Green Shoots
-
Possible Swine Flu Profit Trades
-
Thursday Options Update: VMW, FXI, AGN, WYE, XRT & COH
-
Dividend Stocks to Avoid
-
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
-
After a Dividend Freeze: Hold or Sell?
-
Lessons from the Volatility Shock of 2008
-
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
-
Wall Street Breakfast: Must-Know News
-
A Look at M & A Arbitrage Activity